Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FCYZX
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $103,491
Award facts
- Contract value 100% obligated
- $103,490.97 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $103,490.97 to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 ml pen injectors on July 29, 2025, with an ultimate completion date of July 30, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The pharmaceutical product will be delivered to the contractor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. Dupixent is a biologic medication used to treat conditions including eczema, asthma, and chronic rhinosinusitis, making this delivery order part of the agency's broader pharmaceutical supply chain supporting military and veteran healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. This prime contract vehicle provides comprehensive global pharmaceutical support to military healthcare programs and enables the company to supply a broad range of brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains. AmerisourceBergen's federal contracting demonstrates consistent capability to fulfill open competition requirements for specialized medical commodities serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare customers.
Quick answers
Who was awarded contract SPE2DB25FCYZX?
SPE2DB25FCYZX was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 29, 2025.
How much is contract SPE2DB25FCYZX worth?
The government has obligated $103,491 on SPE2DB25FCYZX.
Is contract SPE2DB25FCYZX an order under another contract?
Yes. SPE2DB25FCYZX is a delivery order under SPE2DB24D1205, an indefinite delivery contract.
Was contract SPE2DB25FCYZX competed?
The extent of competition for SPE2DB25FCYZX was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award